Morse Asset Management, Inc - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Morse Asset Management, Inc ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$113,000
+1.8%
15,400
-6.1%
0.03%
-5.6%
Q2 2017$111,000
-28.4%
16,4000.0%0.04%
-32.1%
Q1 2017$155,000–16,400–0.05%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2017.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders